COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20170609034406N10


Column Value
Trial registration number IRCT20170609034406N10
Full text link
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Dr Afshin Gharekhani

Contact
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

gharekhania@tbzmed.ac.ir

Registration date
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

2023-01-17

Recruitment status
Last imported at : Feb. 21, 2023, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Recruiting

Study design
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

multi-center

Study aim
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

adults aged 18 years or older Positive PCR test for COVID-19 Patients with moderate to severe disease Signs and Symptoms compatible with COVID-19 disease according to the Iranian Ministry of Health protocol Prior to the fifth day of symptoms onset

Exclusion criteria
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Pregnancy Lactation HIV Infection History of taking L-carnitine supplement in the recent Month known immunosuppression condition or any active malignancy Patients with hypothyroidism or hyperthyroidism patients with regular aerobic training (more than 3 times a week with further than 2 hours each time) History of allergy to L-carnitine or its analogues History of or an increased risk for seizure

Number of arms
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Tabriz University of Medical Sciences

Inclusion age min
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

100

primary outcome
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

The length of hospitalization Disease severity Mortality Time to improve clinical symptoms

Notes
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2/Phase 3

Arms
Last imported at : Jan. 17, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 720, "treatment_name": "L-carnitine", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]